Pharma Native ApS: Financial statements 2024
CVR: 44114976
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Native ApS (CVR 44114976) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,537,564 and a net result of DKK 77,485. Equity in the 2024 report amounted to DKK 266,948. The solvency ratio was 60.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,537,564
- Profit/Loss
- DKK 77,485
- Equity
- DKK 266,948
- Total Assets
- DKK 443,799
- Employees
- 1
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma Native ApS has published its interim report for the period June 12, 2023 – December 31, 2023.
About Pharma Native ApS
Pharma Native ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2023. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Jacob Ekstrøm. The company is owned by Jacob Ekstrøm. In 2025, the company reported a gross profit of DKK 989,531 and a net result of DKK 124,011 compared with DKK 77,485 the year before. Equity in the 2025 report amounted to DKK 255,959.